IRCCS Ospedale San Raffaele is one of the leading research institutes in Italy as per volume and quality of scientific output. Since 2001, San Raffaele has been recognized by the Italian Ministry of Health as a research hospital (Istituto di Ricovero e Cura a Carattere Scientifico, IRCCS) with the speciality of Molecular Medicine. This speciality recognizes the multidisciplinary research carried out at the institute, which focuses at both understanding the molecular processes underlying a large number of human diseases and designing new approaches for their treatment.
Research at San Raffaele covers all fields of biomedicine and it deals with the overall biomedical innovation process: from basic discoveries made in the labs to therapy design and test in pre-clinical models, up to first-phase and pilot clinical trials in humans. Thanks to the integration of basic, translational and clinical research, Ospedale San Raffaele is at the forefront in many biomedical areas and provides the best assistance to its patients.
Not only scientific research aims at producing knowledge, but it also uses such knowledge to foster innovation and change people’s lives.
Gianvito Martino, Scientific Director
Understanding, cure and prevention
In order to defeat present and future human diseases, our researchers pursue, at the same time, three goals:
|Dissecting the molecular pathways responsible for a variety of important human diseases|
|Identifying new targets and new therapeutic strategies for such diseases|
|Developing new methods of early diagnosis|
Thanks to the commitment and enthusiasm of its scientists, physicians and students, San Raffaele has already brought to the clinic new and important therapeutic approaches against life threatening diseases.